Literature DB >> 10993102

Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas.

K Ivarsson1, A Ekerydh, I M Fyhr, P O Janson, M Brännström.   

Abstract

BACKGROUND: The chemokine interleukin-8 is present in a variety of tumor types with suggested effects on proliferation, migration, and angiogenesis. Elevated levels of interleukin-8 are present in cyst fluids from malignant ovarian tumors. The origin and potential targets for this chemokine in ovarian tumors were investigated in this study.
METHODS: Interleukin-8 and its receptors were analyzed in 26 ovarian samples, including both normal and neoplastic tissue, with immunohistochemistry, Western blotting, and in situ hybridization.
RESULTS: The mRNA for IL-8 was detected in higher amounts in the epithelial compartments compared to stromal areas, while the IL-8 protein was present in both epithelial and stromal areas, and in cystic formations of the tumors. The tissue levels of IL-8 protein increased with lower differentiation of the tumors. Both types of IL-8 receptors were detected in most specimens. A typical expression pattern for IL-8 receptor A was detected, with expression only on the luminal side of the epithelial tumor cells, while IL-8 receptor B was more evenly distributed in the tissue.
CONCLUSIONS: An increased synthesis of IL-8 during dedifferentiation of the tumor, and a typical expression pattern of the IL-8 receptor A were detected, indicating a function for IL-8 in biology of epithelial ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993102

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  12 in total

1.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ligia Pinto; Patricia Hartge; Troy Kemp; Amanda Black; Mark E Sherman; Louise A Brinton; Ruth M Pfeiffer; Meredith S Shiels; Anil K Chaturvedi; Allan Hildesheim; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

Review 2.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.

Authors:  Himavanth R Gatla; Yue Zou; Mohammad M Uddin; Bipradeb Singha; Pengli Bu; Ales Vancura; Ivana Vancurova
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

Review 4.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

5.  MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.

Authors:  Sangmin Kim; Jeongmin Lee; Myeongjin Jeon; Jeong Eon Lee; Seok Jin Nam
Journal:  Tumour Biol       Date:  2015-11-04

6.  Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.

Authors:  Xipeng Wang; Michael Deavers; Rebecca Patenia; Roland L Bassett; Peter Mueller; Qing Ma; Ena Wang; Ralph S Freedman
Journal:  J Transl Med       Date:  2006-07-06       Impact factor: 5.531

7.  Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.

Authors:  H Nishio; T Yaguchi; J Sugiyama; H Sumimoto; K Umezawa; T Iwata; N Susumu; T Fujii; N Kawamura; A Kobayashi; J Park; D Aoki; Y Kawakami
Journal:  Br J Cancer       Date:  2014-05-27       Impact factor: 7.640

Review 8.  Ovarian cancer: pathology, biology, and disease models.

Authors:  Daniel G Rosen; Gong Yang; Guangzhi Liu; Imelda Mercado-Uribe; Bin Chang; Xue Sherry Xiao; Jingfang Zheng; Feng-Xia Xue; Jinsong Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.

Authors:  Deok-Soo Son; Syder M Kabir; Yuan-Lin Dong; Eunsook Lee; Samuel E Adunyah
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment.

Authors:  Charlotte Rolny; Lorena Capparuccia; Andrea Casazza; Massimiliano Mazzone; Antonella Vallario; Alessandro Cignetti; Enzo Medico; Peter Carmeliet; Paolo M Comoglio; Luca Tamagnone
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.